Skip to main content

Table 1 Characteristics of the study population (N = 21,803), by age groups

From: Urinary incontinence associated with anxiety and depression: the impact of psychotropic drugs in a cross-sectional study from the Norwegian HUNT study

Age at inclusion (years)

Number of women (N)

19–39

N = 4916

40–54

N = 6726

≥55

N = 10,161

All

N = 21,803

N

%

N

%

N

%

N

%

Parity a

 None

1577

32.1

402

6.0

643

6.3

2622

12.0

 1

712

14.5

645

9.6

733

7.2

2090

9.6

 2

1565

31.8

2770

41.2

3296

32.4

7631

35.0

  ≥ 3

1050

21.4

2895

43.0

5472

53.9

9417

43.2

Body mass index a

  < 18.5 (underweight)

72

1.5

40

0.6

70

0.7

182

0.8

 18.5–24.9 (normal)

2515

51.2

2707

40.2

2991

29.4

8213

37.8

 25.0–29.9 (overweight)

1434

29.2

2579

38.3

4245

41.8

8258

38.0

  ≥ 30 (obesity)

879

17.9

1387

20.6

2806

27.6

5072

23.3

Asthma

668

13.6

752

11.2

1211

11.9

2631

12.1

Myocardial infarction

1

0

24

0.4

312

3.1

337

1.5

Cerebral stroke

11

0.2

72

1.1

424

4.2

507

2.3

Diabetes

47

1.0

137

2.0

672

6.6

856

3.9

Continence status a

 Continent

3800

77.3

4735

70.4

6936

68.3

15,471

71.0

 Any UI

1116

22.7

1991

29.6

3225

31.7

6332

29.0

Type of UI (n = 6332) a

 Stress

613

54.9

1015

50.9

1068

33.2

2696

42.6

 Urgency

136

12.2

213

10.7

524

16.2

873

13.8

 Mixed

296

26.5

705

35.4

1471

45.6

2472

39.0

 Other/unclassified

68

6.1

51

2.6

132

4.1

251

4.0

 Missing

3

0.3

7

0.4

30

0.9

40

0.6

Severity of UI (n = 6332) a

 Slight

664

59.5

959

48.2

952

29.5

2575

40.7

 Moderate

398

35.7

888

44.6

1498

46.4

2784

44.0

 Severe

33

3.0

89

4.5

522

16.2

644

10.2

 Very severe

1

0.1

14

0.7

101

3.1

116

1,8

 Missing

20

1.8

41

2.1

152

4.7

213

3.4

Anxiety

HADS-A 8–10.9

569

11.6

714

10.6

1106

10.9

2389

11.0

  Antidepressant status (n = 2389) a

   Using

62

10.9

114

16.0

211

19.1

387

16.2

   Not using

507

89.1

600

84.0

895

80.9

2002

83.8

HADS-A ≥ 11

311

6.3

442

6.6

563

5.5

1316

6.0

  Antidepressant status (n = 1316) a

   Using

62

19.9

130

29.4

197

35.0

389

29.6

   Not using

249

80.1

312

70.6

366

65.0

927

70.4

Depression

HADS-D 8–10.9

215

4.4

377

5.6

839

8.3

1431

6.6

  Antidepressant status (n = 1431) a

   Using

32

14.9

94

24.9

178

21.2

304

21.2

   Not using

183

85.1

283

75.1

661

78.8

1127

78.8

HADS-D ≥ 11

60

1.2

146

2.2

240

2.4

446

2.0

  Antidepressant status (n = 446)) a

   Using

21

35.0

49

33.6

85

35.4

155

34.8

   Not using

39

65.0

97

66.4

155

64.6

291

65.2

Psychotropic drug use b

 Opioid analgesics

245

5.0

540

8.0

912

9.0

1697

7.8

 Non-opioid analgesics

136

2.8

385

5.7

891

8.8

1412

6.5

 Anti-epileptics

47

1.0

133

2.0

213

2.1

393

1.8

 Lamotrigin

21

0.4

26

0.4

35

0.3

82

0.4

 Anti-parkinson drug

1

0

7

0.1

87

0.9

95

0.4

 Anti-psychotics

34

0.7

107

1.6

238

2.3

379

1.7

 Anxiolytics

72

1.5

283

4.2

817

8.0

1172

5.4

 Hypnotics/sedatives

91

1.9

391

5.8

1693

16.7

2175

10.0

 Anti-depressants (all)

234

4.8

588

8.7

1125

11.1

1947

8.9

 SSRI

163

3.3

358

5.3

653

6.4

1174

5.4

  1. UI Urinary incontinence
  2. HADS Hospital anxiety and depression scale
  3. SSRI selective serotonin receptor inhibitor
  4. aColumn-distribution
  5. b Drug use was defined as dispensed prescription last 6 months